Authors:
Gidding, CEM
Germain, GS
Dilling, MB
Meeuwsen-de Boer, TGJ
Ashmun, RA
de Graaf, SSN
Veverka, KA
Kamps, WA
Houghton, PJ
Citation: Cem. Gidding et al., The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma celllines and xenograft models, CANC CHEMOT, 45(1), 2000, pp. 21-30
Authors:
Pasqualini, R
Koivunen, E
Kain, R
Lahdenranta, J
Sakamoto, M
Stryhn, A
Ashmun, RA
Shapiro, LH
Arap, W
Ruoslahti, E
Citation: R. Pasqualini et al., Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis, CANCER RES, 60(3), 2000, pp. 722-727
Authors:
McKenzie, PP
Guichard, SM
Middlemas, DS
Ashmun, RA
Danks, MK
Harris, LC
Citation: Pp. Mckenzie et al., Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G(1) checkpoint function is attenuated, CLIN CANC R, 5(12), 1999, pp. 4199-4207
Authors:
Hosoi, H
Dilling, MB
Shikata, T
Liu, LN
Shu, L
Ashmun, RA
Germain, GS
Abraham, RT
Houghton, PJ
Citation: H. Hosoi et al., Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells, CANCER RES, 59(4), 1999, pp. 886-894